期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 86, 期 5, 页码 1092-1101出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2021.01.059
关键词
acne; cardiovascular disease; comorbidity; Crohn's disease; depression; dermatologist; diabetes mellitus; dissecting cellulitis of the scalp; down syndrome; dyslipidemia; generalized anxiety disorder; guidelines; herpes zoster; hidradenitis suppurativa; hypertension; inflammatory bowel disease; lymphoma; metabolic syndrome; North America; obesity; pilonidal disease; polycystic ovary syndrome; pyoderma gangrenosum; screening; sexual dysfunction; smoking; spondyloarthritis; substance use; suicide; systemic; ulcerative colitis
类别
资金
- Building Interdisciplinary Research Careers in Women's Health of the National Institutes of Health [K12D085850]
- National Institutes of Health [NIAMS K32 AR074531]
This study aims to provide evidence-based screening recommendations for comorbidities associated with HS. Screening recommendations were made based on the consistency and quality of existing studies, disease prevalence and magnitude of association, as well as benefits, harms, and feasibility of screening. A total of 30 comorbidities were recommended for screening in order to improve patients' quality of life and health status.
Background: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk. Objective: To provide evidence-based screening recommendations for comorbidities linked to HS. Methods: Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population. The screening recommendation for each comorbidity was informed by the consistency and quality of existing studies, disease prevalence, and magnitude of association, as well as benefits, harms, and feasibility of screening. The level of evidence and strength of corresponding screening recommendation were graded by using the Strength of Recommendation Taxonomy (SORT) criteria. Results: Screening is recommended for the following comorbidities: acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. It is also recommended to screen patients with Down syndrome for HS. The decision to screen for specific comorbidities may vary with patient risk factors. The role of the dermatologist in screening varies according to comorbidity. Limitations: Screening recommendations represent one component of a comprehensive care strategy. Conclusions: Dermatologists should support screening efforts to identify comorbid conditions in HS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据